Search | IOVS | ARVO Journals

Showing 1 – 20 of 25

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Steroidome in the Human aqueous humor (AH) and serum and in AH of central serous choroidopathy (CSCR)

Francine F Behar-Cohen; Marta Zola; Jean-Louis Bourges; Thara Jaworski; Elodie Bousquet; Min Zhao; Eric Pussard

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3503.

ARVO Annual Meeting Abstract June 2022

Correlation of Paravascular Inner Retinal Defects with Posterior Vitreous Detachment Using En Face OCT

Veronica Romero Morales; Elodie Bousquet; swathi somisetty; Ahmad Santina; Neda Abraham; Anthony Lu; Meira Fogel Levin; Timothy J. Peiris; Brian Lee; David Sarraf

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1009 – F0256.

ARVO Annual Meeting Abstract June 2022

Non-Neovascular Fluid in Age Related Macular Degeneration: Observe and Extend

Ahmad Santina; Veronica Romero Morales; Neda Abraham; Swathi Somisetty; Meira Fogel Levin; Elodie Bousquet; Eric Nudleman; Srinivas R Sadda; David Sarraf

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):360 – F0191.

ARVO Annual Meeting Abstract June 2022

OCT angiography to assess outcomes of type 1 macular neovascularization in eyes with treatment naïve exudative AMD

swathi somisetty; Elodie Bousquet; Ahmad Santina; Veronica Romero Morales; Neda Abraham; David Sarraf

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1343 – F0177.

ARVO Annual Meeting Abstract June 2022

Late hyperfluorescent plaque in type 1 choroidal neovascularization in age-related macular degeneration and central serous chorioretinopathy

Marta Zola; Elodie Bousquet; Catherine Favard; Anthony Gigon; Irmela Mantel; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2667.

ARVO Annual Meeting Abstract June 2022

Birdshot chorioretinitis in patients aged 80 and older

Louis DEBILLON; Elodie Bousquet; Pierre Duraffour; Souhila Kecili; Jennifer E Thorne; Dominique Monnet; Antoine Brézin

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3919 – A0462.

ARVO Annual Meeting Abstract June 2020

Lipocalin 2 is decreased in the serum of patients with Central Serous Chorioretinopathy: Towards a biomarker?

Francine F Behar-Cohen; Thara Jaworski; Elodie Bousquet; Alexandre Matet; Camille Gobeaux; Suzanne Yzer; Jérémie Canonica

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3192.

ARVO Annual Meeting Abstract July 2019

Phenotype of Central serous chorioretinopathy in female

TIMSIT AURELIE; Elodie Bousquet; Irmela Mantel; martine elalouf; Ramin Tadayoni; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1546.

ARVO Annual Meeting Abstract July 2019

Central serous chorioretinopathy: Hypofluorescent areas on late-phase indocyanine angiography are risk factor of serous retinal detachment

Ari Shinojima; Elodie Bousquet; Alain Gaudric; Chadi Mehanna; Carlo Lavia; Ramin Tadayoni

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1586.

ARVO Annual Meeting Abstract July 2019

Choroidal structural changes in patients with Birdshot Chorioretinopathy

Elodie Bousquet; Sawsen Salah; Antoine Brézin; Dominique Monnet; Neha Khandelwa; Rupesh Vijay Agrawal

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1841.

ARVO Annual Meeting Abstract September 2016

Optical Coherence Tomography angiography of Flat Irregular Pigment Epithelium Detachment in Central Serous Chorioretinopathy

Elodie Bousquet; Valerie Krivosic; Ramin Tadayoni; Alain Gaudric

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5480.

Physiology and Pharmacology April 2016

Anti-Inflammatory Effect of Dexamethasone Controlled Released From Anterior Suprachoroidal Polyurethane Implants on Endotoxin-Induced Uveitis in Rats

PDF

Juliana Barbosa Saliba; Lorena Vieira; Gabriella Maria Fernandes-Cunha; Gisele Rodrigues Da Silva; Sílvia Ligório Fialho; Armando Silva-Cunha; Elodie Bousquet; Marie-Christine Naud; Eliane Ayres; Rodrigo Lambert Oréfice; Meriem Tekaya; Laura Kowalczuk; Min Zhao; Francine Behar-Cohen
TAGS: anti-inflammatory agents, dexamethasone, endotoxins, eye, implants, polyurethanes, rats, uveitis, implantation procedure, catabolism
Invest. Ophthalmol. Vis. Sci.. 2016; 57(4):1671-1679. https://doi.org/10.1167/iovs.15-18127

ARVO Annual Meeting Abstract June 2015

Sleep disorders : a risk factor of central serous chorioretinopathy

Mariam Dhundass; elodie bousquet; Mathieu Lehmann; Pierre-Raphael Rothschild; Antoine P Brezin; Francine Behar Cohen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1799.

ARVO Annual Meeting Abstract June 2015

Choroidal mast cells in retinal pathology: a potential target for intervention

Francine F Behar-Cohen; elodie bousquet; Min Zhao; Brigitte Goldenberg; Lorena Vieira; Marie-Christine Naud; Ciara Bergin; Yvonne De Kozak

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4720.

ARVO Annual Meeting Abstract June 2015

Effects of Mineralocorticoid Receptor Antagonist on Diabetic Retina Using Goto-Kakizaki Rat

Min Zhao; Charlotte Andrieu-Soler; elodie bousquet; Rinath Levy; Francisco Halili; Alejandro Arboleda; Esther Rodríguez-Villagra; Irene Bravo-Osuna; Rocio Herrero-Vanrell; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2271.

ARVO Annual Meeting Abstract April 2014

Spironolactone reduces sub retinal fluid and choroidal thickness in CSR

Francine F Behar-Cohen; Elodie Bousquet; Talal Beydoun; Min Zhao; Pierre Raphael Rothschild; Alain Gaudric; Emmanuel Curis; François Chast

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1924.

ARVO Annual Meeting Abstract April 2014

Expression of Water/ion Channels and Inflammatory Markers in the Retina of Goto-Kakizaki Type 2 Diabetic Rat: Contribution of Mineralocorticoid Receptor Pathway

Min Zhao; Elodie Bousquet; Jean-Claude Jeanny; Patricia Lassiaz; Francine F Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5823.

ARVO Annual Meeting Abstract June 2013

Mineralocorticoid Receptor Antagonism in the Treatment of Chronic Central Serous Chorioretinopathy: First Pilot Study

Min Zhao; Elodie Bousquet; Francine Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2813.

ARVO Annual Meeting Abstract June 2013

Anti-VEGF therapy inhibits microglial activation and migration in the retina

Aude Couturier; Elodie Bousquet; Min Zhao; Brigitte Goldenberg; Yvonne De Kozak; Francine Behar-Cohen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5598.

ARVO Annual Meeting Abstract June 2013

Mineralocorticoid receptor antagonists for the treatment of central serous chorioretinopathy: Mechanistic rationale

Francine Behar-Cohen; Isabelle Celerier; Elodie Bousquet; Jean-Claude Jeanny; Frederic Jaisser; Nicolette Farman

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6360.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Steroidome in the Human aqueous humor (AH) and serum and in AH of central serous choroidopathy (CSCR)

Correlation of Paravascular Inner Retinal Defects with Posterior Vitreous Detachment Using En Face OCT

Non-Neovascular Fluid in Age Related Macular Degeneration: Observe and Extend

OCT angiography to assess outcomes of type 1 macular neovascularization in eyes with treatment naïve exudative AMD

Late hyperfluorescent plaque in type 1 choroidal neovascularization in age-related macular degeneration and central serous chorioretinopathy

Birdshot chorioretinitis in patients aged 80 and older

Lipocalin 2 is decreased in the serum of patients with Central Serous Chorioretinopathy: Towards a biomarker?

Phenotype of Central serous chorioretinopathy in female

Central serous chorioretinopathy: Hypofluorescent areas on late-phase indocyanine angiography are risk factor of serous retinal detachment

Choroidal structural changes in patients with Birdshot Chorioretinopathy

Optical Coherence Tomography angiography of Flat Irregular Pigment Epithelium Detachment in Central Serous Chorioretinopathy

Anti-Inflammatory Effect of Dexamethasone Controlled Released From Anterior Suprachoroidal Polyurethane Implants on Endotoxin-Induced Uveitis in Rats

Sleep disorders : a risk factor of central serous chorioretinopathy

Choroidal mast cells in retinal pathology: a potential target for intervention

Effects of Mineralocorticoid Receptor Antagonist on Diabetic Retina Using Goto-Kakizaki Rat

Spironolactone reduces sub retinal fluid and choroidal thickness in CSR

Expression of Water/ion Channels and Inflammatory Markers in the Retina of Goto-Kakizaki Type 2 Diabetic Rat: Contribution of Mineralocorticoid Receptor Pathway

Mineralocorticoid Receptor Antagonism in the Treatment of Chronic Central Serous Chorioretinopathy: First Pilot Study

Anti-VEGF therapy inhibits microglial activation and migration in the retina

Mineralocorticoid receptor antagonists for the treatment of central serous chorioretinopathy: Mechanistic rationale

To View More...

You must be signed into an individual account to use this feature.